In this study, we found an association between the DNMT1 rs2162560 SNP and self-perceived cognitive impairment in breast cancer patients; carriers of the A allele experienced lower odds of self-reported cognitive decline in two cognitive domains: concentration and functional interference. The gene discussed is DNMT1; the disease is Mental deterioration.